Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | (264.7%) | (305.8%) | (236.6%) | (457.5%) | (821.7%) | (204.2%) | (121.9%) | 11.5% | (3.2%) | (59.0%) | (81.4%) | (49.0%) | (0.5%) | 18.6% | 171.6% | 43.1% | 69.7% | 60.1% | 79.1% | 73.0% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is (16.5%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Vertex Pharmaceuticals Incorporated have been 52.0% over the past three years, and 59.8% over the past five years.
As of today, Vertex Pharmaceuticals Incorporated's Return on Invested Capital (ROIC) is (16.5%), which is higher than industry median of (123.1%). It indicates that Vertex Pharmaceuticals Incorporated's Return on Invested Capital (ROIC) is Good.